Therapiewechsel von Ranibizumab zu Aflibercept bei rezidivierender oder persistierender exsudativer altersbedingter Makuladegeneration
Crossref DOI link: https://doi.org/10.1007/s00347-014-3137-6
Published Online: 2014-12-20
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ziegler, M.
Heimes, B.
Book, B.
Dietzel, M.
Zeimer, M.
Spital, G.
Gutfleisch, M.
Pauleikhoff, D.
Lommatzsch, A.
Text and Data Mining valid from 2014-12-20